Angiogenesis, vascular endothelial growth factor and the endometrium

Human Reproduction Update

Volumn 4, Issue 5, 1998, Pages 509-519

  Smith, S K ^a  

^a UNIVERSITY OF CAMBRIDGE   (United Kingdom)

Author keywords

Angiogenesis; Endometrium; Human; Menorrhagia; Vascular endothelial growth factor

Indexed keywords

ANGIOGENIC FACTOR; EPIDERMAL GROWTH FACTOR; ESTRADIOL; FIBROBLAST GROWTH FACTOR; LEVONORGESTREL; MEDROXYPROGESTERONE ACETATE; MESSENGER RNA; PLATELET DERIVED ENDOTHELIAL CELL GROWTH FACTOR; PROGESTERONE; RECEPTOR SUBTYPE; THROMBOSPONDIN 1; THYMIDINE PHOSPHORYLASE; TRANSFORMING GROWTH FACTOR; TRANSFORMING GROWTH FACTOR BETA; TUMOR NECROSIS FACTOR; VASCULOTROPIN; VASCULOTROPIN RECEPTOR;

ANGIOGENESIS; ANIMAL CELL; BLOOD CLOTTING; BLOOD VESSEL; CELL MIGRATION; CELL PROLIFERATION; CONFERENCE PAPER; ENDOMETRIUM; FEMALE; GENETIC TRANSCRIPTION; HUMAN; HUMAN CELL; HUMAN TISSUE; MENORRHAGIA; NONHUMAN; PRIORITY JOURNAL; RAT; STROMA CELL; TISSUE DISTRIBUTION;

ANIMALS; CELL DIVISION; CELL MOVEMENT; ENDOMETRIUM; ENDOTHELIAL GROWTH FACTORS; FEMALE; GROWTH SUBSTANCES; HUMANS; LYMPHOKINES; MENORRHAGIA; MULTIGENE FAMILY; NEOVASCULARIZATION, PHYSIOLOGIC; VASCULAR ENDOTHELIAL GROWTH FACTOR A; VASCULAR ENDOTHELIAL GROWTH FACTORS;

EID: 0032406244     PISSN: 13554786     EISSN: None     Source Type: Journal    
DOI: 10.1093/humupd/4.5.509     Document Type: Conference Paper

References (130)

1. Achen, M.G., Jeltsch, M., Kukk, E. et al. (1998) Vascular endothelial growth factor D (VEGF-D) is a ligand for the tyrosine kinases VEGF receptor 2 (Flk 1) and VEGF receptor 3 (Flt4). Proc. Natl Acad. Sci. USA, 95, 548-553.
2. Adams, J.C. (1997) Thrombospondin-1. Int. J. Biochem. Cell Biol., 29, 861-865.
3. Banks, R.E., Forbes, M.A., Kinsey, S.E. et al. (1998) Release of the angiogenic cytokine vascular endothelial growth factor (VEGF) from platelets: significance for VEGF measurements and cancer biology. Br. J. Cancer, 77, 956-964.
4. Barleon, B., Totzke, F., Herzog, C. et al. (1997) Mapping of the sites for ligand binding and receptor dimerization at the extracellular domain of the vascular endothelial growth factor receptor FLT-1. J. Biol. Chem., 272, 10382-10388.
5. Basilico, C. and Moscatelli, D. (1992) The FGF family of growth factors and oncogenes, Adv, Cancer Res., 59, 115-165.
6. Bonnar, J. and Sheppard, B.L. (1996) Treatment of menorrhagia during menstruation: randomised controlled trial of ethamsylate, mefenamic acid, and tranexamic acid. Br. Med. J., 313, 579-582.
7. Brogi, E., Wu, T., Namiki, A. and Isner, J.M. (1994) Indirect angiogenic cytokines upregulate VEGF and bFGF gene expression in vascular smooth muscle cells, whereas hypoxia upregulates VEGF expression only. Circulation, 90, 649-652.
8. Brooks, P.C., Clark, R.A.F. and Cheresh, D.A. (1994) Requirement of vascular integrin alpha(v)beta3 for angiogenesis. Science, 264, 569-571.
9. Bruner, K.L., Rodgers, W.H., Gold, L.I. et al. (1995) Transforming growth factor beta mediates the progesterone suppression of an epithelial metalloproteinase by adjacent stroma in the human endometrium. Proc. Natl Acad. Sci. USA, 92, 7362-7366.
10. Bunn, H.F. and Poyton, R.O. (1996) Oxygen sensing and molecular adaptation to hypoxia. Physiol. Rev., 76, 839-885.
11. Cameron, I.T., Davenport, A.P., Van Papendorp, C. et al. (1992) Endothelin-like immunoreactivity in human endometrium. J. Reprod. Fertil., 95, 623-628.
12. Cameron, I.T., Van Papendorp, C.L., Palmer, R.M.J. et al. (1993) Relationship between nitric oxide synthesis and increase in systolic blood pressure in women with hypertension in pregnancy. Hypertension Preg., 12, 85-92.
13. Cameron, I.T., Bacon, C.R., Collett, G.P. and Davenport, A.P. (1995) Endothelin expression in the uterus. J. Steroid Biochem. Mol. Biol., 53, 209-214.
14. Cao, Y., Chen, H., Zhou, L. et al. (1996) Heterodimers of placenta growth factor/vascular endothelial growth factor: endothelial activity, tumor cell expression, and high affinity binding to FIk-1/KDR. J. Biol. Chem., 271, 3154-3162.
15. Charnock-Jones, D.S., Sharkey, A.M., Rajput-Williams, J. et al. (1993) Identification and localization of alternately spliced mRNAs for vascular endothelial growth factor in human uterus and estrogen regulation in endometrial carcinoma cell lines. Biol. Reprod., 48, 1120-1128.
16. Charnock-Jones, D.S., Sharkey, A.M., Boocock, C.A. et al. (1994) Vascular endothelial growth factor receptor localization and activation in human trophoblast and choriocarcinoma cells. Biol. Reprod., 51, 524-530.
17. Christiaens, G., Sixma, J.J. and Haspels, A.A. (1980) Morphology of haemostasis in menstrual endometrium. Br. J. Obstet. Gynaecol., 87, 425-439.
18. Clark, D.E., Smith, S.K., Sharkey, A.M. and Charnock-Jones, D.S. (1996) Localization of VEGF and expression of its receptors flt and KDR in human placenta throughout pregnancy. Hum. Reprod., 11, 1090-1098.
19. Cohen, T., Nahari, D., Cerem, L.W. et al. (1996) Interleukin 6 induces the expression of vascular endothelial growth factor. J. Biol. Chem., 271, 736-741.
20. Conn, G., Bayne, M.L., Soderman, D.D. et al. (1990) Amino acid and cDNA sequences of a vascular endothelial cell mitogen that is homologous to platelet-derived growth factor. Proc. Natl Acad. Sci. USA, 87, 2628-2632.
21. Connolly, D.T., Heuvelman, D.M., Nelson, R. et al. (1989) Tumor vascular permeability factor stimulates endothelial cell growth and angiogenesis. J. Clin. Invest., 84, 1470-1478.
22. Cullinan-Bove, K. and Koos, R.D. (1993) Vascular endothelial growth factor/vascular permeability factor expression in the rat uterus: rapid stimulation by estrogen correlates with estrogen-induced increases in uterine capillary permeability and growth. Endocrinology, 133, 829-837.
23. Damert, A., Ikeda, E. and Risau, W. (1997) Activator-protein-1 binding potentiates the hypoxia-inducible factor-1-mediated hypoxia-induced transcriptional activation of vascular-endothelial growth factor expression in C6 glioma cells. Biochem. J., 327, 419-123.
24. Davis-Smyth, T., Chen, H., Park, J. et al. (1996) The second immunoglobulin-like domain of the VEGF tyrosine kinase receptor Flt-1 determines ligand binding and may initiate a signal transduction cascade. EMBO J., 15, 4919-4927.
25. De Vries, C., Escobedo, J.A., Ueno, H. et al. (1992) The fms-like tyrosine kinase, a receptor for vascular endothelial growth factor. Science, 255, 989-991.
26. Dumont, D.J., Fong, G.H., Puri, M.C. et al. (1995) Vascularization of the mouse embryo: a study of flk-1, tek, tie, and vascular endothelial growth factor expression during development. Dev. Dyn., 203, 80-92.
27. Esch, F., Ueno, N., Baird, A. et al. (1985) Primary structure of bovine brain acidic fibroblast growth factor (FGF). Biochem. Biophys. Res. Commun., 133, 554-562.
28. Ferrara, N. and Henzel, W.J. (1989) Pituitary follicular cells secrete a novel heparin-binding growth factor specific for vascular endothelial cells. Biochem. Biophys. Res. Commun., 161, 851-858.
29. Ferriani, R.A., Charnock-Jones, D.S., Prentice, A. et al. (1993) Immunohistochemical localization of acidic and basic fibroblast growth factors in normal human endometrium and endometriosis and the detection of their mRNA by polymerase chain reaction. Hum. Reprod., 8, 11-16.
30. Fett, J.W., Strydom, D.J., Lobb, R.R. et al. (1985) Isolation and characterization of angiogenin, an angiogenic protein from human carcinoma cells. Biochemistry, 24, 5480-5486.
31. Finnis, C., Dodsworth, N., Pollitt, C.E. et al. (1993) Thymidine phosphorylase activity of platelet-derived endothelial cell growth factor is responsible for endothelial cell mitogenicity. Eur. J. Biochem., 212, 201-210.
32. Flamme, I. and Risau, W. (1995) Mechanism of blood vessel formation. Ann. Anat., 177, 493-502.
33. Folkman, J. (1997) Addressing tumor blood vessels. Nature Biotechnol., 15, 510.
34. Folkman, J. and D'Amore, P.A. (1996) Blood vessel formation: what is its molecular basis? Cell, 87, 1153-1155.
35. Folkman, J. and Shing, Y. (1992) Angiogenesis. J. Biol. Chem., 267, 10931-10934.
36. Fong, G.H., Rossant, J., Gertsenstein, M. and Breitman, M.L. (1995) Role of the Flt-1 receptor tyrosine kinase in regulating the assembly of vascular endothelium. Nature, 376, 66-70.
37. Forsythe, J.A., Jiang, B.H., Iyer, N.V. et al. (1996) Activation of vascular endothelial growth factor gene transcription by hypoxia-inducible factor 1. Mol. Cell. Biol., 16, 4604-4613.
38. Gitay-Goren, H., Halaban, R. and Neufeld, G. (1993) Human melanoma cells but not normal melanocytes express vascular endothelial growth factor receptors. Biochem. Biophys. Res. Commun., 190, 702-709.
39. Gleeson, N., Devitt, M., Sheppard, B.L. and Bonnar, J. (1993) Endometrial fibrinolytic enzymes in women with normal menstruation and dysfunctional uterine bleeding. Br. J. Obstet. Gynaecol., 100, 768-771.
40. Goodger, A.M. and Rogers, P.A.W. (1994) Endometrial endothelial cell proliferation during the menstrual cycle. Hum. Reprod., 9, 399-405.
41. Gospodarowicz, D., Abraham, J.A. and Schilling, J. (1989) Isolation and characterization of a vascular endothelial cell mitogen produced by pituitary-derived folliculo stellate cells. Proc. Natl Acad. Sci. USA, 86, 7311-7315.
42. Greb, R.R., Heikinheimo, O., Williams, R.F. et al. (1997) Vascular endothelial growth factor in primate endometrium is regulated by oestrogen-receptor and progesterone-receptor ligands in vivo. Hum. Reprod., 12, 1280-1292.
43. Grimwood, J., Bicknell, R. and Rees, M.C.P. (1995) The isolation, characterization and culture of human decidual endothelium. Hum. Reprod., 10, 2142-2148.
44. Hanahan, D. (1997) Signaling vascular morphogenesis and maintenance. Science, 277, 48-50.
45. Hanahan, D. and Folkman, J. (1996) Patterns and emerging mechanisms of the angiogenic switch during tumorigenesis. Cell, 86, 353-364.
46. Haney, A.F. (1991) The pathogenesis and aetiology of endometriosis. In Thomas, E. and Rock, J. (eds), Modern Approaches to Endometriosis. Kluwer Academic Publishers, Norwell, MA, pp. 3-19.
47. Horowitz, J.R., Rivard, A., Van der Zee, R. et al. (1997) Vascular endothelial growth factor/vascular permeability factor produces nitric oxide-dependent hypotension: evidence for a maintenance role in quiescent adult endothelium. Arteriosclerosis Thromb. Vasc. Biol., 17, 2793-2800.
48. Houck, K.A., Ferrara, N., Winer, J. et al. (1991) The vascular endothelial growth factor family: identification of a fourth molecular species and characterization of alternative splicing of RNA. Mol. Endocrinol., 5, 1806-1814.
49. Houck, K.A., Leung, D.W., Rowland, A.M. et al. (1992) Dual regulation of vascular endothelial growth factor bioavailability by genetic and proteolytic mechanisms. J. Biol. Chem., 267, 26031-26037.
50. Hourihan, H.M., Sheppard, B.L. and Bonnar, J. (1986) A morphometric study of the effect of oral norethisterone or levonorgestrel on endometrial blood vessels. Contraception, 34, 603-612.
51. Hyder, S.M., Stancel, G.M., Chiappetta, C. et al. (1996) Uterine expression of vascular endothelial growth factor is increased by estradiol and tamoxifen. Cancer Res., 56, 3954-3960.
52. Hynes, R.O. (1992) Integrins: versatility, modulation, and signaling in cell adhesion. Cell, 69, 11-25.
53. Hynes, R.O. and Lander, A.D. (1992) Contact and adhesive specificities in the associations, migrations, and targeting of cells and axons. Cell, 68, 303-322.
54. Iruela-Arispe, M.L., Porter, P., Bornstein, P. and Sage, E.H. (1996) Thrombospondin-1, an inhibitor of angiogenesis, is regulated by progesterone in the human endometrium. J. Clin. Invest., 97, 403-412.
55. Joukov, V., Pajusola, K., Kaipainen, A. et al. (1996) A novel vascular endothelial growth factor, VEGF-C, is a ligand for the Flt4 (VEGFR-3) and KDR (VEGFR-2) receptor tyrosine kinases. EMBO J., 15, 290-298.
56. Keck, P.J., Hauser, S.D., Krivi, G. et al. (1989) Vascular permeability factor, an endothelial cell mitogen related to PDGF. Science, 246, 1309-1312.
57. Keyt, B.A., Berleau, L.T., Nguyen, H.V. et al. (1996) The carboxyl-terminal domain (111-165) of vascular endothelial growth factor is critical for its mitogenic potency. J. Biol. Chem., 271, 7788-7795.
58. Kjerulff, K.H., Erickson, B.A. and Langenberg, P.W. (1996) Chronic gynecological conditions reported by US women: findings from the National Health Interview Survey, 1984 to 1992. Am. J. Public Health, 86, 195-199.
59. Klagsbrun, M. and D'Amore, P.A. (1991) Regulators of angiogenesis. Annu. Rev. Physiol., 53, 217-239.
60. Kooy, J., Taylor, N.H., Healy, D.L. and Rogers, P.A.W. (1996) Endothelial cell proliferation in the endometrium of women with menorrhagia and in women following endometrial ablation. Hum. Reprod., 11, 1067-1072.
61. Laitinen, M., Zachary, I., Breier, G. et al. (1997) VEGF gene transfer reduces intimai thickening via increased production of nitric oxide in carotid arteries. Hum. Gene Therapy, 8, 1737-1744.
62. Leibovich, S.J., Polverini, P.J. and Shepard, H.M. (1987) Macrophage-induced angiogenesis is mediated by tumor necrosis factor-alpha. Nature, 329, 630-632.
63. Leung, D.W., Cachianes, G., Kuang, W.J. et al. (1989) Vascular endothelial growth factor is a secreted angiogenic mitogen. Science, 246, 1306-1309.
64. Levy, A.P., Levy, N.S., Loscalzo, J. et al. (1995a) Regulation of vascular endothelial growth factor in cardiac myocytes. Circ. Res., 76, 758-766.
65. Levy, A.P., Levy, N.S., Wegner, S. and Goldberg, M.A. (1995b) Transcriptional regulation of the rat vascular endothelial growth factor gene by hypoxia. J. Biol. Chem., 270, 13333-13340.
66. Li, J., Perrella, M.A., Tsai, J.C. et al. (1995) Induction of vascular endothelial growth factor gene expression by interleukin-1 beta in rat aortic smooth muscle cell. J. Biol. Chem., 270, 308-312.
67. Li, X.F., Gregory, J. and Ahmed, A. (1994) Immunolocalisation of vascular endothelial growth factor in human endometrium. Growth Factors, 11, 277-282.
68. Ludwig, H., Metzger, H. and Frauli, M. (1976) The re-epithelialization of endometrium after menstrual desquamation. Arch. Gynaekol., 221, 51-60.
69. Maglione, D., Guerriero, V., Viglietto, G. et al. (1993) Two alternative mRNAs coding for the angiogenic factor, placenta growth factor (PIGF), are transcribed from a single gene of chromosome 14. Oncogene, 8, 925-931.
70. Maisonpierre, P.C., Suri, C., Jones, P.F. et al. (1997) Angiopoietin-2, a natural antagonist for Tie 2 that disrupts in vivo angiogenesis. Science, 277, 55-60.
71. Management of Menorrhagia (1995) Effective Health Care. University of Leeds, UK.
72. Mandriota, S.J. and Pepper, M.S. (1997) Vascular endothelial growth factor-induced in vitro angiogenesis and plasminogen activator expression are dependent on endogenous basic fibroblast growth factor. J. Cell Sci., 110, 2293-2302.
73. Markee, J.E. (1940) Menstruation in intraocular endometrial transplants in the rhesus monkey. Contrib. Embryol., 28, 219-308.
74. Matthews, W., Jordan, C.T., Gavin, M. et al. (1991) A receptor tyrosine kinase cDNA isolated from a population of enriched primitive hematopoietic cells and exhibiting close genetic linkage to c-kit. Proc. Nad Acad. Sci. USA, 88, 9026-9030.
75. McLaren, J., Prentice, A., Charnock-Jones, D.S. et al. (1996) Vascular endothelial growth factor is produced by peritoneal fluid macrophages in endometriosis and is regulated by ovarian steroids. J. Clin. Invest., 98, 482-489.
76. Millauer, B., Wizigmann-Voos, S., Schnurch, H. et al. (1993) High affinity VEGF binding and developmental expression suggest Flk-1 as a major regulator of vasculogenesis and angiogenesis. Cell, 72, 835-846.
77. Miyamoto, M., Naruo, K.I., Seko, C. et al. (1993) Molecular cloning of a novel cytokine cDNA encoding the ninth member of the fibroblast growth factor family, which has a unique secretion property. Mol. Cell. Biol., 13, 4251-4259.
78. Moghaddam, A., Zhang, H.T., Fan, T.P. et al. (1995) Thymidine phosphorylase is angiogenic and promotes tumor growth. Proc. Natl Acad. Sci. USA, 92, 998-1002.
79. Murohara, T., Horowitz, J.R., Silver, M. et al. (1998) Vascular endothelial growth factor/vascular permeability factor enhances vascular permeability via nitric oxide and prostacyclin. Circulation, 97, 99-107.
80. Nelson, K.G., Takahashi, T., Bossert, N.L. et al. (1991) Epidermal growth factor replaces estrogen in the stimulation of female genital-tract growth and differentiation. Proc. Natl Acad. Sci. USA, 88, 21-25.
81. Odlind, V.S. and Fraser, I.S. (1990) Contraception and menstrual bleeding disturbances: a clinical overview. In D'Arcangues, C., Newton, J.R., Frazer, I.S. and Ocllind, V. (eds) Contraception and Mechanisms of Endometrial Bleeding. Cambridge University Press, Cambridge, UK, pp. 5-32.
82. Olofsson, B., Pajusola, K., Kaipainen, A. et al. (1996) Vascular endothelial growth factor B, a novel growth factor for endothelial cells. Proc. Natl Acad. Sci. USA, 93, 2576-2581.
83. Osteen, K.G., Rodgers, W.H., Gaire, M. et al. (1994) Stromal-epithelial interaction mediates steroidal regulation of metalloproteinase expression in human endometrium. Proc. Natl Acad. Sci. USA, 91, 10129-10133.
84. Papapetropoulos, A., Garcia-Cardena, G., Madri, J.A. and Sessa, W.C. (1997) Nitric oxide production contributes to the angiogenic properties of vascular endothelial growth factor in human endothelial cells. J. Clin. Invest., 100, 3131-3139.
85. Park, J.E., Keller, G.A. and Ferrara, N. (1993) The vascular endothelial growth factor (VEGF) isoforms: differential deposition into the subepithelial extracellular matrix and bioactivity of extracellular matrix-bound VEGF. Mol. Biol. Cell, 4, 1317-1326.
86. Pepper, M.S., Ferrara, N., Orci, L. and Montesano, R. (1991) Vascular endothelial growth factor (VEGF) induces plasminogen activators and plasminogen activator inhibitor-1 in microvascular endothelial cells. Biochem. Biophys. Res. Commun., 181, 902-906.
87. Pertovaara, L., Kaipainen, A., Mustonen, T. et al. (1994) Vascular endothelial growth factor is induced in response to transforming growth factor-beta in fibroblastic and epithelial cell. J. Biol. Chem., 269, 6271-6274.
88. Piegsa, K., Calder, A., Davis, J.A. et al. (1997) Endometrial status in post-menopausal women on long-term continuous combined hormone replacement therapy (Kliofem¿). A comparative study of endometrial biopsy, outpatient hysteroscopy and transvaginal ultrasound. Eur. J. Obstet. Gynecol. Reprod. Biol., 72, 175-180.
89. Poltorak, Z., Cohen, T., Sivan, R. et al. (1997) VEGF145, a secreted vascular endothelial growth factor isoform that binds to extracellular matrix. J. Biol. Chem., 272, 7151-7158.
90. Presta, M. (1988) Sex hormones modulate the synthesis of basic fibroblast growth factor in human endometrial adenocarcinoma cells: implications for the neovascularization of normal and neoplastic endometrium. J. Cell. Physiol., 137, 593-597.
91. Preston, J.T., Cameron, I.T., Adams, E.J. and Smith, S.K. (1995) Comparative study of tranexamic acid and norethisterone in the treatment of ovulatory menorrhagia. Br. J. Obstet. Gynaecol., 102, 401-406.
92. Puri, M.C., Rossant, J., Alitalo, K. et al. (1995) The receptor tyrosine kinase TIE is required for integrity and survival of vascular endothelial cells. EMBO J., 14, 5884-5891.
93. Rawdanowicz, T.J., Hampton, A.L., Nagase, H. et al. (1994) Matrix metalloproteinase production by cultured human endometrial stromal cells: identification of interstitial collagenase, gelatinase-A, gelatinase-B, and stromelysin-1 and their differential regulation by interleukin-1 alpha and tumor necrosis factor-α. J. Clin. Endocrinol. Metab., 79, 530-536.
94. Rees, M.C.P., Demers, L.M., Anderson, A.B.M. and Turnbull, A.C. (1984) A functional study of platelets in menstrual fluid. Br. J. Obstet. Gynaecol., 91, 667-672.
95. Risau, W. (1995) Differentiation of endothelium. FASEB J., 9, 926-933.
96. Risau, W. (1997) Mechanisms of angiogenesis. Nature, 386, 671-674.
97. Roberts, A.B., Sporn, M.B., Assoian, R.K. et al. (1986) Transforming growth factor type beta: rapid induction of fibrosis and angiogenesis in vivo and stimulation of collagen formation in vitro. Proc. Natl Acad. Sci. USA, 83, 4167-4171.
98. Rodgers, W.H., Matrisian, L.M., Giudice, L.C. et al. (1994) Patterns of matrix metalloproteinase expression in cycling endometrium imply differential functions and regulation by steroid hormones. J. Clin. Invest., 94, 946-953.
99. Rogers, P.A.W., Abberton, S. and Susil, B. (1992) Endothelial cell migratory signal produced by human endometrium during the menstrual cycle. Hum. Reprod., 7, 1061-1066.
100. Rogers, P.A.W., Au, S.L. and Affandi, B. (1993) Endometrial microvascular density during the normal menstrual cycle and following exposure to long-term levonorgestrel. Hum. Reprod., 8, 1396-1404.
101. Sangha, R.K., Xiao Feng, L., Shams, M. and Ahmed, A. (1997) Fibroblast growth factor receptor-1 is a critical component for endometrial remodeling: localization and expression of basic fibroblast growth factor and FGF-R1 in human endometrium during the menstrual cycle and decreased FGF-R1 expression in menorrhagia. Lab. Invest., 77, 389-402.
102. Sato, T.N., Tozawa, Y., Deutsch, U. et al. (1995) Distinct roles of the receptor tyrosine kinases Tie-1 and Tie-2 in blood vessel formation. Nature, 376, 70-74.
103. Schreiber, A.B., Winkler, M.E. and Derynck, R. (1986) Transforming growth factor-alpha: a more potent angiogenic mediator than epidermal growth factor. Science, 232, 1250-1253.
104. Semenza, G.L., Roth, P.H., Fang, H.M. and Wang, G.L. (1994) Transcriptional regulation of genes encoding glycolytic enzymes by hypoxia-inducible factor 1. J. Biol. Chem., 269, 23757-23763.
105. Senger, D.R., Ledbetter, S.R., Claffey, K.P. et al. (1996) Stimulation of endothelial cell migration by vascular permeability factor/vascular endothelial growth factor through cooperative mechanisms involving the alpha(v)beta3 integrin, osteopontin, and thrombin. Am. J. Pathol., 149, 293-305.
106. Shalaby, F., Rossant, J., Yamaguchi, T.P. et al. (1995) Failure of blood-island formation and vasculogenesis in Flk-1 deficient mice. Nature, 376, 62-66.
107. Sharkey, A.M., Cooper, J.C., Balmforth, J.R. et al. (1996) Maternal plasma levels of vascular endothelial growth factor in normotensive pregnancies and in pregnancies complicated by pre-eclampsia. Eur. J. Clin. Invest., 26, 1182-1185.
108. Shen, H., Clauss, M., Ryan, J. et al. (1993) Characterization of vascular permeability factor/vascular endothelial growth factor receptors on mononuclear phagocytes. Blood, 81, 2767-2773.
109. Shibuya, M., Yamaguchi, S., Yamane, A. et al. (1990) Nucleotide sequence and expression of a novel human receptor-type tyrosine kinase gene (flt) closely related to the fms family. Oncogene, 5, 519-524.
110. Shifren, J.L., Tseng, J.F., Zaloudek, C.J. et al. (1996) Ovarian steroid regulation of vascular endothelial growth factor in the human endometrium: implications for angiogenesis during the menstrual cycle and in the pathogenesis of endometriosis. J. Clin. Endocrinol. Metab., 81, 3112-3118.
111. Shima, D.T., Deutsch, U. and D'Amore, P.A. (1995) Hypoxic induction of vascular endothelial growth factor (VEGF) in human epithelial cells is mediated by increases in mRNA stability. FEBS Lett., 370, 203-208.
112. Shweiki, D., Itin, A., Soffer, D. and Keshet, E. (1992) Vascular endothelial growth factor induced by hypoxia may mediate hypoxia-initiated angiogenesis. Nature, 359, 843-845.
113. Siegfried, S., Pekonen, F., Nyman, T. et al. (1997) Distinct patterns of expression of keratinocyte growth factor and its receptor in endometrial carcinoma. Cancer, 79, 1166-1171.
114. Smith, S.K. (1990) The physiology of menstruation. In D'Arcangues, C., Newton, J.R., Frazer, I.S. and Odlind, V. (eds), Contraception and Mechanisms in Endometrial Bleeding. Cambridge University Press, Cambridge, UK, pp. 33-51.
115. Soker, S., Gollamudi-Payne, S., Fidder, H. et al. (1997) Inhibition of vascular endothelial growth factor (VEGF)-induced endothelial cell proliferation by a peptide corresponding to the exon 7-encoded domain of VEGF165. J. biol. Chem., 272, 31582-31588.
116. Stavri, G.T., Hong, Y., Zachary, I.C. et al. (1995) Hypoxia and platelet-derived growth factor-BB synergistically upregulate the expression of vascular smooth muscle cells. FEBS Lett., 358, 311-315.
117. Telfer, J.F., Lyall, F., Norman, J.E. and Cameron, I.T. (1995) Identification of nitric oxide synthase in human uterus. Hum. Reprod., 10, 19-23.
118. Terman, B.I., Carrion, M.E., Kovacs, E. et al. (1991) Identification of a new endothelial cell growth factor receptor tyrosine kinase. Oncogene, 6, 1677-1683.
119. Tischer, E., Mitchell, R., Hartman, T. et al. (1991) The human gene for vascular endothelial growth factor: multiple protein forms are encoded through alternative exon splicing. J. Biol. Chem., 266, 11947-11954.
120. Torry, D.S. and Torry, R.J. (1997) Angiogenesis and the expression of vascular endothelial growth factor in endometrium and placenta. Am. J. Reprod. Immunol., 37, 21-29.
121. Torry, D.S., Holt, V.J., Keenan, J.A. et al. (1996) Vascular endothelial growth factor expression in cycling human endometrium. Fertil. Steril., 66, 72-80.
122. Tseng, L., Zhang, J., Peresleni, T.Y. and Goligorsky, M.S. (1996) Cyclic expression of endothelial nitric oxide synthase mRNA in the epithelial glands of human endometrium. J. Soc. Gynecol. Invest., 3, 33-38.
123. Van Belle, E., Witzenbichler, B., Chen, D. et al. (1998) Potentiated angiogenic effect of scatter factor/hepatocyte growth factor via induction of vascular endothelial growth factor: the case for paracrine amplification of angiogenesis. Circulation, 97, 381-390.
124. Vincenti, V., Cassano, C., Rocchi, M. and Persico, M.G. (1996) Assignment of the vascular endothelial growth factor gene to human chromosome 6p21 .3. Circulation, 93, 1493-1495.
125. Wang, G.L. and Semenza, G.L. (1993) Characterization of hypoxia-inducible factor 1 and regulation of DNA binding activity by hypoxia. J. Biol. Chem., 268, 21513-21518.
126. Wang, G.L. and Semenza, G.L. (1995) Purification and characterization of hypoxia-inducible factor 1. J. Biol. Chem., 270, 1230-1237.
127. Warren, R.S., Yuan, H., Matli, M.R. et al. (1996) Induction of vascular endothelial growth factor by insulin-like growth factor 1 in colorectal carcinoma. J. Biol. Chem., 271, 29483-29488.
128. Wheeler-Jones, C., Abu-Ghazaleh, R., Cospedal, R. et al. (1997) Vascular endothelial growth factor stimulates prostacyclin production and activation of cytosolic phospholipase A2 in endothelial cells via p42/p44 mitogen-activated protein kinase. FEBS Lett., 420, 28-32.
129. Yamada, Y., Nezu, J.I., Shimane, M. and Hirata, Y. (1997) Molecular cloning of a novel vascular endothelial growth factor, VEGF-D. Genomics, 42, 483-488.
130. Zhang, L., Mackenzie, I.Z., Rees, M.C.P. and Bicknell, R. (1997) Regulation of the expression of the angiogenic enzyme platelet-derived endothelial cell growth factor/thymidine phosphorylase in endometrial isolates by ovarian steroids and cytokines. Endocrinology, 138, 4921-4930.